Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PALATINE, Ill., April 16, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced receipt from the United States Patent and Trademark Office (the "USPTO") of U.S. Patent No....
-
PALATINE, Ill., April 2, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $600,000 and a commitment for additional funding of up to...
-
PALATINE, Ill., March 15, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $6.0 million or $0.08 per common share for calendar year 2006 compared to a...
-
PALATINE, Ill., March 15, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced results of Study AP-ADF-102 ("Study 102"), a phase II clinical trial for OxyADF (oxycodone...
-
PALATINE, Ill., Feb. 20, 2007 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has completed the draw down of the $2.0 million November, 2006 bridge funding commitment...
-
PALATINE, Ill., Dec. 11, 2006 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR), today announced receipt from the United States Patent and Trademark Office of a Notice of Allowance for a...
-
PALATINE, Ill., Nov. 30, 2006 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $534,000 and a commitment for additional funding of up to...
-
PALATINE, Ill., Nov. 3, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced a net loss of $3.1 million or $0.01 per share for the quarter ending September 30, 2006 compared to...
-
PALATINE, Ill., Oct. 20, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $620,000 under a term loan agreement (the "Loan") with Essex...
-
PALATINE, Ill., Sept. 22, 2006 (PRIMEZONE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $489,000 under a term loan agreement (the "Loan") with Essex...